Nateglinide vs CYP2C9 Inhibitors (Moderate)

Interacting Drugs
Nateglinide
vs
CYP2C9 Inhibitors (Moderate)
Security Level
Minor, Monitor Therapy
Mechanism
CYP2C9 Inhibitors (Moderate): May decrease the metabolism of CYP2C9 Substrates (High risk).
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Nateglinide vs CYP2C9 Inhibitors (Moderate)


Other Interactions of Nateglinide

We are Developing Our database, More results coming soon.

Other Interactions of CYP2C9 Inhibitors (Moderate)

We are Developing Our database, More results coming soon.